Complete author affiliations and disclosures, and other CME information, are available at the end of this activity.
Release Date: October 11, 2006; Valid for credit through October 11, 2007
All other healthcare professionals completing continuing education credit for this activity will be issued a certificate of participation.
Physicians should only claim credit commensurate with the extent of their participation in the activity.
October 11, 2006 — Regular consumption of carbonated cola drinks may increase risk for low bone mineral density (BMD) in women, according to the results of the Framingham Osteoporosis Study reported in the October issue of the American Journal of Clinical Nutrition.
"Soft drink consumption may have adverse effects on bone mineral density (BMD), but studies have shown mixed results," write Katherine L. Tucker, MD, from Tufts University in Boston, Massachusetts, and colleagues. "In addition to displacing healthier beverages, colas contain caffeine and phosphoric acid (H3PO4), which may adversely affect bone."
Using dual-energy x-ray absorptiometry, the investigators measured BMD at the spine and at 3 hip sites in 1413 women and in 1125 men in the Framingham Osteoporosis Study. Dietary intake was evaluated with a food frequency questionnaire. Each BMD measure was regressed on the frequency of soft drink consumption after adjustment for body mass index, height, age, energy intake, physical activity score, smoking, alcohol use, total calcium intake, total vitamin D intake, caffeine from noncola sources, season of measurement, and, for women, menopausal status and estrogen use.
Cola intake was associated with lower BMD at each hip site in women but not in men (P < .001 - .05). However, it was not linked with lower BMD at the spine for women or men. Compared with those who consumed less than 1 serving of cola per month, those with daily cola intake had a mean BMD 3.7% lower at the femoral neck and 5.4% lower at Ward's area. These results were similar with diet cola and to a lesser extent with decaffeinated cola.
There were no significant relationships between noncola carbonated beverage consumption and BMD. Although total phosphorus intake was not significantly higher in daily cola consumers than in nonconsumers, the calcium-to-phosphorus ratios were lower.
Study limitations include possibly incomplete control of confounding.
"Intake of cola, but not of other carbonated soft drinks, is associated with low BMD in women," the authors write. "Additional research is needed to confirm these findings.... Unless additional evidence rules out an effect, women who are concerned about osteoporosis may want to avoid the regular use of cola beverages."
The United States Department of Agriculture and the National Institutes of Health supported this study. The authors have disclosed no relevant financial relationships.
Am J Clin Nutr. 2006;84:936-942.
Increased cola intake has been demonstrated to reduce BMD in children, and several mechanisms may be responsible for this association. Caffeine is a defined risk factor for osteoporosis, and high fructose corn syrup may reduce bone density. In addition, colas contain phosphoric acid, which can reduce serum calcium levels and promote higher levels of parathyroid hormone. This hormone, in turn, can increase bone turnover and lead to osteoporosis.
The current cohort study examines the BMD in relation to cola intake among men and women.
This article is intended for primary care clinicians, endocrinologists, orthopedists, and other specialists who care for patients at risk for osteoporosis.
The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.
For Physicians
![]()
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Medscape Medical News has been reviewed and is acceptable for up to 200 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins 09/01/06. Term of approval is for 1 year from this date. This activity is approved for 0.25 Prescribed credits. Credit may be claimed for 1 year from the date of this activity. AAFP credit is subject to change based on topic selection throughout the accreditation year.![]()
AAFP Accreditation Questions
For Nurses
This Activity is sponsored by Medscape Continuing Education Provider Unit: Medscape is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
Approved for 0.3 contact hour(s) of continuing education for RNs and NPs; None of these credits is in the area of pharmacology.
Provider Number: 6FDKKC-PRV-05
As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Laurie Barclay, MD
is a freelance reviewer and writer for Medscape.
Disclosure: Laurie Barclay, MD, has disclosed no relevant financial relationships.
Charles P Vega, MD
Associate Professor, Residency Director, Department of Family Medicine, University of California, Irvine
Disclosure: Charles Vega, MD, FAAFP, has disclosed that he has received grants for educational activities from Pfizer.